Post by
Risk_Assess999 on Nov 29, 2017 2:42pm
Going back to $14
CMED wants to go it alone without ACB.
Comment by
Risk_Assess999 on Nov 29, 2017 2:45pm
CMED CEO will eat words about ACB being over-inflated ... he should have looked closer at his own stock.